Technology
Health
Biotechnology

Protagonist Therapeutics

416

$6.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+1.02%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PTGX and other stocks, options, ETFs, and crypto commission-free!

About PTGX

Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Read More Smythe on August 22, 2006 and is headquartered in Newark, CA.

CEO
Dinesh V. Patel
Employees
73
Headquarters
Newark, California
Founded
2006
Market Cap
189.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
178.98K
High Today
$7.17
Low Today
$6.66
Open Price
$6.95
Volume
119.43K
52 Week High
$16.67
52 Week Low
$4.47

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Research And Development
Pharmaceutical

PTGX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, After Hours

People Also Bought

Viking Therapeutics

53,940

$5.08

+3.25%

Viking Therapeutics

53,940

$5.08

+3.25%

Stemline

3,680

$5.23

+9.87%

Catalyst Pharmaceuticals

79,147

$4.41

+6.01%

Aurora Cannabis

892,171

$0.89

+4.44%

You May Also Like

IBHE
HCI
STXS
SONVY
NEW
MBWM
TFIV
FBMS
FIHD
ALTS
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy PTGX

Market Price$6.95
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell PTGX stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up